Mohammed T Lilo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mohammed T Lilo

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal for Immunotherapy of Cancer|March 28, 2017

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockadeEvan J Lipson, Mohammed T Lilo, Aleksandra Ogurtsova, et al.

Journal of Clinical Pathology|July 6, 2014

NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomasRebecca J Asch-Kendrick, Mark A Samols, Mohammed T Lilo, et al.

Acta Cytologica|November 28, 2016

Serous Cystadenoma of the Pancreas: Potentials and Pitfalls of a Preoperative Cytopathologic DiagnosisMohammed T Lilo, Christopher J VandenBussche, Derek B Allison, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal for Immunotherapy of Cancer|March 28, 2017

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockadeEvan J Lipson, Mohammed T Lilo, Aleksandra Ogurtsova, et al.

Journal of Clinical Pathology|July 6, 2014

NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomasRebecca J Asch-Kendrick, Mark A Samols, Mohammed T Lilo, et al.

Acta Cytologica|November 28, 2016

Serous Cystadenoma of the Pancreas: Potentials and Pitfalls of a Preoperative Cytopathologic DiagnosisMohammed T Lilo, Christopher J VandenBussche, Derek B Allison, et al.

Pageof 2